← Back to Screener
SciSparc Ltd. Ordinary Shares (SPRC)
Price$4.23
Favorite Metrics
Price vs S&P 500 (26W)-96.50%
Price vs S&P 500 (4W)-14.03%
Market Capitalization$2.50M
All Metrics
Book Value / Share (Quarterly)$0.03
P/TBV (Annual)0.56x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-31.33
Price vs S&P 500 (YTD)-68.03%
Net Profit Margin (TTM)-2023.43%
EPS (TTM)$-1.51
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-1.51
EPS (Annual)$-203.89
ROI (Annual)-76.63%
Gross Margin (Annual)38.74%
Net Profit Margin (5Y Avg)-285.45%
Cash / Share (Quarterly)$26.01
ROA (Last FY)-60.73%
EBITD / Share (TTM)$-146.91
ROE (5Y Avg)-99.80%
Operating Margin (TTM)-1884.16%
Cash Flow / Share (Annual)$-89.09
P/B Ratio13.89x
P/B Ratio (Quarterly)292.56x
Net Income / Employee (Annual)$-3
Net Interest Coverage (TTM)-43.04x
ROA (TTM)-181.51%
EPS Incl Extra (Annual)$-203.89
Current Ratio (Annual)5.36x
Quick Ratio (Quarterly)0.52x
3-Month Avg Trading Volume0.14M
52-Week Price Return-91.35%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.03
P/S Ratio (Annual)1.91x
Asset Turnover (Annual)0.13x
52-Week High$94.50
Operating Margin (5Y Avg)-364.65%
EPS Excl Extra (Annual)$-203.89
Tangible BV CAGR (5Y)-27.06%
26-Week Price Return-87.75%
Quick Ratio (Annual)4.96x
13-Week Price Return-54.53%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)0.55x
Enterprise Value$3.066
Asset Turnover (TTM)0.09x
Book Value / Share Growth (5Y)73.71%
Revenue / Employee (Annual)$1
Pretax Margin (Annual)-573.20%
Cash / Share (Annual)$35.91
3-Month Return Std Dev124.15%
Net Income / Employee (TTM)$-5
ROE (Last FY)-77.07%
Net Interest Coverage (Annual)-11.96x
EPS Basic Excl Extra (Annual)$-203.89
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)6.05x
EPS Incl Extra (TTM)$-1.51
Receivables Turnover (Annual)81.63x
ROI (TTM)-215.66%
P/S Ratio (TTM)5.42x
Pretax Margin (5Y Avg)-308.84%
Revenue / Share (Annual)$42.38
Tangible BV / Share (Annual)$116.51
Price vs S&P 500 (52W)-126.45%
Year-to-Date Return-63.89%
5-Day Price Return44.21%
EPS Normalized (Annual)$-203.89
ROA (5Y Avg)-65.05%
Net Profit Margin (Annual)-481.16%
Month-to-Date Return20.77%
Cash Flow / Share (TTM)$-1.11
EBITD / Share (Annual)$-221.74
Operating Margin (Annual)-560.18%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-93.73%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-1.51
P/TBV (Quarterly)29.02x
P/B Ratio (Annual)0.46x
Pretax Margin (TTM)-2041.65%
Book Value / Share (Annual)$142.33
Price vs S&P 500 (13W)-57.39%
Beta1.45x
Revenue / Share (TTM)$7.97
ROE (TTM)-231.72%
52-Week Low$2.98
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SPRCSciSparc Ltd. Ordinary Shares | 5.42x | — | — | — | $4.23 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
SciSparc Ltd is a clinical-stage biopharmaceutical company developing cannabinoid-based immunotherapy products and holds patents in the immunotherapy field. The company operates two segments: pharmaceutical development targeting regulatory approval, and e-commerce sales of hemp-derived consumer products including supplements and topical treatments manufactured in the United States.